• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE LTD FREESTYLE LIBRE 3; CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE LTD FREESTYLE LIBRE 3; CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 72081-01
Device Problem Low Readings (2460)
Patient Problems Dehydration (1807); Fatigue (1849); Hyperglycemia (1905); Dizziness (2194)
Event Date 03/10/2023
Event Type  Injury  
Manufacturer Narrative
The product has been requested back for an investigation.At this time product has not yet been returned.An extended investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.The device history records (dhrs) for the freestyle libre sensor and freestyle libre sensor kit were reviewed and the dhrs showed the freestyle libre sensor and sensor kit passed all tests prior to release.If the product is returned, a physical investigation will be performed, and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A customer reported a low reading with the adc device.Customer obtained a sensor scan result of 143mg/dl and was compared to 394mg/dl obtained on lab results and experienced symptoms of dizziness, lightheadedness, fast paced heartbeat, dehydration, and lethargy.Customer was unable to self-treat and had contact with a healthcare professional in the emergency room who administered saline solution through an iv and insulin by pen/injection as treatment for a diagnosis of hyperglycemia.The results when plotted on a parkes error grid, fell into the "c" zone, showing the difference in values to be clinically significant.No further information was provided.There was no report of death or permanent impairment associated with this event.
 
Manufacturer Narrative
Sensor (b)(6) has been returned and investigated.Visual inspection performed on the returned sensor and no issue was observed.Data was extracted using approved software, and extraction was successful.The watermark was not observed at the base of the tail.The returned sensor was further investigated and de-cases.Performed an internal visual inspection on the sensor¿s pcba (printed circuit board assembly); no issues were observed.The returned battery voltage was measured to be within specification range.Performed an smu (source measurement unit) test to ensure the sensor's electronics were functioning correctly, and the returned unit did not have any glucose reading issues.Poise voltage and sensor thermistor testing were both within specification, indicating the sensor was providing accurate glucose readings.No malfunction or product deficiency was identified.Therefore, this issue is not confirmed.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A customer reported a low reading with the adc device.Customer obtained a sensor scan result of 143mg/dl and was compared to 394mg/dl obtained on lab results and experienced symptoms of dizziness, lightheadedness, fast paced heartbeat, dehydration, and lethargy.Customer was unable to self-treat and had contact with a healthcare professional in the emergency room who administered saline solution through an iv and insulin by pen/injection as treatment for a diagnosis of hyperglycemia.The results when plotted on a parkes error grid, fell into the "c" zone, showing the difference in values to be clinically significant.No further information was provided.There was no report of death or permanent impairment associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 3
Type of Device
CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE LTD
range road
witney 12345 -700
UK  12345-7001
Manufacturer Contact
audra fuentes
1360 south loop road
alameda, CA 94502-7001
5107495297
MDR Report Key16746812
MDR Text Key313359872
Report Number2954323-2023-14705
Device Sequence Number1
Product Code QLG
UDI-Device Identifier30357599818006
UDI-Public30357599818006
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K213996
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 08/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/31/2023
Device Model Number72081-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Manufacturer Received07/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/12/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-